GI CELL, 'Allogeneic NK cell therapy' technology to be exported to a company in Türkiye: 'Signed a letter of intent'

GI Cell speeds up developing of allogeneic NK cell therapies

GICELL Announces the Preclinical Research Data Demonstrating the Superiority of the NK Cell Mass Culture Platform at the Society for Immunotherapy of Cancer

GICELL Announces Research Collaboration with HK inno.N for next-generation CAR-NK therapy

GI-Cell partners with Helixmith and Cartexell to develop cell therapy technology

BIO-EUROPE SPRING 2022_GICELL corporate presentation